Curebound Strengthens Leadership with Three Key Executive Hires to Accelerate Cancer Research
核心洞察
Curebound (搜索), a San Diego-based cancer (搜索) research accelerator, announced three executive hires: Mary Meyer as Chief Advancement Officer, Scotty Cadet, Ph.D. as Chief Scientific Officer, and Leena Gupta as Chief Financial Officer.
Dr. Cadet brings 17+ years spanning drug discovery through late-stage clinical development, including immuno-oncology work at ImmunityBio that produced an FDA-approved drug.
The new leaders will apply expertise in philanthropy, artificial intelligence, and financial strategy to sharpen Curebound (搜索)'s selection and funding of high-impact cancer (搜索) research.
Curebound (搜索), a community-powered cancer (搜索) research accelerator headquartered in San Diego, announced three key additions to its leadership team: Mary Meyer as Chief Advancement Officer, Scotty Cadet, Ph.D. as Chief Scientific Officer and Vice President of Research, and Leena Gupta as Chief Financial Officer. Together, the three executives bring decades of experience in philanthropy, cancer research, artificial intelligence, budget management, and strategic planning to support Curebound's mission of funding bold science in early cancer detection and personalized therapy to accelerate cancer research and save lives.
A Philanthropy Leader with a Track Record of Transformational Gifts
Meyer brings more than 35 years of experience leading high-performing advancement teams across healthcare, medical research, city government, and international cooperation. During 21 years at Scripps Health, she served as Corporate Vice President of the Scripps Health Foundation and, as Regional Senior Director, led capital campaigns for Scripps Mercy Hospital, Scripps Cancer (搜索) Center, and Scripps Cardiovascular Institute, closing lead gifts ranging from $10 million to $45 million.
At Curebound (搜索), Meyer will lead advancement strategy and oversee major campaigns across philanthropy, foundations, endowments, and corporate partnerships, while expanding relationships with research institutions and leading the development, marketing, sponsorship, and community outreach teams.
"I've spent my career building the relationships and resources that drive discovery, and I can't imagine a more urgent or inspiring mission," said Meyer. "I look forward to partnering with our donors, board of directors, scientific advisors, and the broader San Diego community to fund the science that gives cancer (搜索) patients and families more time."
A Scientist Bridging the Discovery-to-Patient Pipeline
Dr. Cadet brings more than 17 years of experience spanning drug discovery through late-stage clinical development — from regenerative medicine research at Lonza and the National Institute on Aging (NIH) to immuno-oncology clinical development at ImmunityBio, work that has produced several patents and an FDA-approved drug. Cadet holds a doctorate in cancer (搜索) biology from Sanford Burnham Prebys Medical Discovery Institute, with graduate training in molecular and cellular pharmacology from the University of Wisconsin–Madison, where he also trained as a stem cell scientist. Most recently, at LabCorp, he co-led a sizable contract research organization department before joining Curebound (搜索).
At Curebound (搜索), Cadet will lead the organization's internal research group and Scientific Advisory Board in identifying and selecting the research most likely to bridge the gap between discovery and patients, bringing scientific rigor and a proprietary selection process leveraging AI technology to enhance the organization's research investment decisions.
"We must close the gap between funding and science to advance early detection, develop better treatments, and give patients hope for cures in the near future," said Cadet.
A Finance Leader with Deep Nonprofit Expertise
Gupta is a strategic CFO and finance leader with more than 25 years advising organizations across healthcare, nonprofit, and private sectors, with deep expertise supporting foundations, fundraising platforms, and mission-driven enterprises. She previously served as a Managing Director at Ascent, U.S. Bank's ultra-high-net-worth multi-family office, before launching her fractional CFO practice, and co-founded several ventures, including Coin Up, a mobile donation platform recognized with grants from the Gates Foundation and others. Gupta serves as Treasurer on the Board of Governors for the San Diego Foundation, a $1.7 billion endowment, and is a founding board member of the CFO Leadership Council and the MIT Sloan Club of San Diego. She holds an MBA from MIT Sloan and a degree in public accounting from Loyola University Chicago.
At Curebound (搜索), Gupta will guide the organization's financial strategy, oversee budgeting and reporting, and ensure regulatory compliance to support Curebound's steadily growing revenue that will fund a greater number of impactful cancer (搜索) research studies.
"By strengthening Curebound (搜索)'s financial foundation, we can direct more resources toward the innovative research that brings cures within reach," said Gupta.
A Pivotal Moment for Cancer Research Funding
Curebound (搜索) Chief Executive Officer Robin Toft said Meyer, Cadet, and Gupta are joining Curebound at a pivotal moment.
"Mary's extraordinary track record in philanthropy will expand the already impressive donor community that fuels our work. Scotty's scientific rigor and AI experience will sharpen how we identify and fund the research proposals with the highest likelihood of helping patients. And Leena's financial expertise will strengthen Curebound (搜索)'s foundation and sustain our ability to fund more research," said Toft. "All three share our conviction that cures are within reach, and their leadership and experience will help us get there faster."
Curebound (搜索) is a community-powered cancer (搜索) research accelerator dedicated to advancing breakthrough science into cures. By breaking down barriers, investing in high-impact cancer studies, and forging powerful collaborations among top scientists, advocates, entrepreneurs, and philanthropists, Curebound advances bold science toward better detection and treatments to give patients and families more time. Headquartered in San Diego, a leading global hub for life sciences and cancer research, Curebound is driven by one goal: cures in our lifetime.